Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: Feasibility Study of the Head and Neck Survivorship Tool: Assessment and Recommendations (HN-STAR)
Feasibility study update for the Head and Neck Survivorship Tool (HN-STAR) completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Study of PF-07263689 in Participants With Selected Advanced Solid Tumors [Phase 1]
Phase 1 trial of PF-07263689 in selected advanced solid tumors was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: Self-Care for Head and Neck Cancer Survivors With Lymphedema and Fibrosis [NA]
A completed clinical trial evaluating self-care for head and neck cancer survivors with lymphedema and fibrosis; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Investigation of Two Swallowing Therapy Models During Radiation Therapy for Head and Neck Cancer [NA]
A completed clinical trial evaluating two swallowing therapy models during radiation therapy for head and neck cancer; results posted in 202…
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: Optimising Patient Experience in Head and Neck Radiotherapy [Phase 3]
Phase 3 clinical trial investigating patient experience optimization in head and neck radiotherapy; status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: Study Evaluating The Role of ClO2 on Mucositis for Pt. Undergoing Head/Neck Radiotherapy [Phase 2]
Phase 2 clinical trial evaluating the role of chlorine dioxide (ClO2) in managing mucositis for patients undergoing head and neck radiothera…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma [Phase 1, Phase 2]
Clinical trial update on palbociclib combined with cetuximab and IMRT for locally advanced head and neck squamous cell carcinoma (phases 1 a…
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Outcomes of Patients Treated With Proton or Photon Therapy [NA]
Clinical trial update reporting on dual-energy CT for plan quality, dose-delivery accuracy, and simulated outcomes in proton vs photon thera…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer [Phase 1]
A Phase 1 imaging trial using the CCR2-targeting radiotracer 64Cu-DOTA-ECL1i in head and neck cancer was terminated, with results posted on …
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy [Phase 2]
Phase 2 clinical trial evaluating adjuvant nivolumab after salvage resection in head and neck cancer patients previously treated with defini…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Opioid Therapy vs Multimodal Analgesia in Head and Neck Cancer [Phase 2]
Phase 2 trial comparing opioid therapy to multimodal analgesia for head and neck cancer patients, including those with radiation-induced muc…
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: MSC in Patients With Xerostomia Post XRT in Head and Neck Cancer [Phase 1]
Phase 1 clinical trial evaluating mesenchymal stem cell therapy for xerostomia after radiotherapy in head and neck cancer. Results have been…
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating single-agent armodafinil for patient-reported fatigue after radiation therapy in head and neck cancer; study comp…
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: HARE-40: HPV Anti-CD40 RNA vaccinE [Phase 1, Phase 2]
Phase 1/2 clinical trial update for HARE-40, an HPV-targeted CD40 RNA vaccine, completed enrollment.
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: Blinded Dry Mouth Spray Crossover Study [NA]
A completed crossover study evaluating a blinded dry mouth spray for xerostomia, including patients with head and neck cancer and xerostomia…
-
CLINICAL_TRIALS trial_result · 2024-01-29Clinical Trial Update: A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer [Phase 2]
Phase 2 multicenter study evaluating intensive concomitant chemoradiotherapy with filgrastim for locoregionally advanced head and neck cance…
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors [Phase 2]
Phase 2 trial evaluating checkpoint inhibition in combination with external beam radiotherapy for solid tumors; study is completed.
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL [Phase 1, Phase 2]
Phase 1/2 trial update for CX-2029 in solid tumors and DLBCL completed; aims to identify safe and active dose levels.
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer [Phase 2]
Phase 2 trial update evaluating the safety and efficacy of combining an immune checkpoint inhibitor with radiochemotherapy in locally advanc…
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and efficacy of a vaccination targeting HPV16-related cancers in head and neck, cervical, and anal cancers…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial PROCLAIM-CX-2009 evaluating safe and active doses of CX-2009 for selected solid tumors; trial status terminated with results…
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer [Phase 2]
Phase 2 trial evaluating induction total parenteral nutrition followed by nivolumab and radiation for locoregionally advanced laryngeal and …
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating enoblituzumab in combination with retifanlimab or tebotolimab in head and neck cancer was terminated, with results …
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer [Phase 3]
Phase 3 trial comparing high dose versus low dose Iodine-131 with or without rhTSH in differentiated thyroid cancer; current status is unkno…
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating durvalumab with cetuximab in previously treated recurrent or metastatic head and neck squamous cell carcin…